Abp-788.mp4 ⭐

If the video discusses trial results, it likely highlights these key areas:

: A potent tubulin inhibitor that kills the cancer cell once the antibody binds to the HER2 receptor and is internalized. ABP-788.mp4

: Recent data from the ACE-Breast-06 study showed that ARX788 can cross the blood-brain barrier, providing a 25% objective response rate for patients with active brain metastases. If the video discusses trial results, it likely

: Ongoing research is exploring its use in patients with lower levels of HER2 expression, who previously had limited targeted therapy options. 2. Mechanism of Action If the video discusses trial results